Lista de obras - Anna Gluba-Brzózka - Dominio Público Uruguay

Acute coronary syndromes in patients with chronic kidney disease

artículo científico publicado en 2013

An update on biomarkers of heart failure in hypertensive patients

artículo científico

Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?

artículo científico publicado en 2017

Are polymorphisms within endothelial nitric oxide synthase good predictors of coronary artery disease?

scientific article published on 22 September 2010

Assessment of the relationship between selected cardiovascular risk factors and the indices of intima-media thickness and coronary artery calcium score in various stages of chronic kidney disease.

artículo científico publicado en 2015

Biochemical markers in the prediction of contrast-induced acute kidney injury

artículo científico publicado en 2020

Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension

artículo científico publicado en 2015

Biomarkers of cardiovascular risk in haemodialysis patients.

artículo científico publicado en 2017

Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients

artículo científico publicado en 2019

Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome

artículo científico publicado en 2019

Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.

artículo científico publicado en 2016

Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

artículo científico publicado en 2016

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis

artículo científico publicado en 2016

Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?

Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.

artículo científico publicado en 2016

Evaluation of the effectiveness of methods of endoscopic treatment of bleeding from the duodenal mucosa

artículo científico publicado en 2015

Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

artículo científico publicado en 2015

Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors.

artículo científico publicado en 2009

Heart function disturbances in chronic kidney disease - echocardiographic indices

artículo científico publicado en 2014

High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease.

artículo científico publicado en 2016

Hypertension - Current Natural Strategies to Lower Blood Pressure.

artículo científico publicado en 2017

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients.

artículo científico publicado en 2018

Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study

artículo científico publicado en 2009

Lipid-modifying effects of nutraceuticals: An evidence-based approach

artículo científico publicado en 2016

Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients.

artículo científico publicado en 2016

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

artículo científico publicado en 2016

Markers of increased cardiovascular risk in patients with chronic kidney disease.

artículo científico publicado en 2014

Metabolic syndrome and renal disease

artículo científico publicado en 2012

Molecular mechanisms of statin intolerance

artículo científico publicado en 2016

Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.

artículo científico publicado en 2017

Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases

scientific article published on 03 November 2020

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases

artículo científico publicado en 2017

Pharmacogenomics of Hypertension Treatment ⬇️

artículo científico publicado en 2020

Prevention of sudden cardiac death in patients with chronic kidney disease.

artículo científico publicado en 2012

Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease.

artículo científico publicado en 2017

Role and significance of statins in the treatment of hypertensive patients

artículo científico publicado en 2009

Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures

artículo científico publicado en 2020

Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge

artículo científico publicado en 2015

Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance

artículo científico publicado en 2013

Statins in patients with chronic kidney disease: why, who and when?

artículo científico publicado en 2010

Sudden cardiac death in CKD patients

artículo científico

The Effect of Diet on the Survival of Patients with Chronic Kidney Disease

artículo científico publicado en 2017

The Influence of Inflammation on Anemia in CKD Patients

scientific article published on 22 January 2020

The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.

artículo científico publicado en 2016

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease

scientific article published on 17 January 2020

The Role of Metabolic Factors in Renal Cancers

scientific article published on 30 September 2020

The Use of Plant Sterols and Stanols as Lipid-Lowering Agents in Cardiovascular Disease

artículo científico publicado en 2017

The assessment of selected markers of cardiac dysfunction in the analysis of cardiovascular risk in dialysis patients

scholarly article by Beata Franczyk et al published August 2017 in Atherosclerosis

The correlation between lipid metabolism disorders and the prostate cancer

artículo científico publicado en 2020

The multi-biomarker approach for heart failure in patients with hypertension.

artículo científico publicado en 2015

The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis

artículo científico publicado en 2017

The risk of atherosclerosis in patients with chronic kidney disease

artículo científico publicado en 2013

The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk

artículo científico publicado en 2017

The role of Toll-like receptors in renal diseases

scientific article published on 23 February 2010

The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study

artículo científico publicado en 2009

The role of polyphenols in cardiovascular disease

artículo científico publicado en 2010

The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis.

artículo científico publicado en 2017

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease

artículo científico publicado en 2013

Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe.

artículo científico publicado en 2017

Lista de obras de Anna Gluba-Brzózka

Acute coronary syndromes in patients with chronic kidney disease

An update on biomarkers of heart failure in hypertensive patients

Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?

Are polymorphisms within endothelial nitric oxide synthase good predictors of coronary artery disease?

Assessment of the relationship between selected cardiovascular risk factors and the indices of intima-media thickness and coronary artery calcium score in various stages of chronic kidney disease.

Biochemical markers in the prediction of contrast-induced acute kidney injury

Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension

Biomarkers of cardiovascular risk in haemodialysis patients.

Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients

Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome

Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.

Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis

Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?

Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?

Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.

Evaluation of the effectiveness of methods of endoscopic treatment of bleeding from the duodenal mucosa

Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors.

Heart function disturbances in chronic kidney disease - echocardiographic indices

High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease.

Hypertension - Current Natural Strategies to Lower Blood Pressure.

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients.

Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study

Lipid-modifying effects of nutraceuticals: An evidence-based approach

Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients.

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Markers of increased cardiovascular risk in patients with chronic kidney disease.

Metabolic syndrome and renal disease

Molecular mechanisms of statin intolerance

Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.

Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases

Pharmacogenomics of Hypertension Treatment ⬇️

Prevention of sudden cardiac death in patients with chronic kidney disease.

Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease.

Role and significance of statins in the treatment of hypertensive patients

Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures

Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge

Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance

Statins in patients with chronic kidney disease: why, who and when?

Sudden cardiac death in CKD patients

The Effect of Diet on the Survival of Patients with Chronic Kidney Disease

The Influence of Inflammation on Anemia in CKD Patients

The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease

The Role of Metabolic Factors in Renal Cancers

The Use of Plant Sterols and Stanols as Lipid-Lowering Agents in Cardiovascular Disease

The assessment of selected markers of cardiac dysfunction in the analysis of cardiovascular risk in dialysis patients

The correlation between lipid metabolism disorders and the prostate cancer

The multi-biomarker approach for heart failure in patients with hypertension.

The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis

The risk of atherosclerosis in patients with chronic kidney disease

The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk

The role of Toll-like receptors in renal diseases

The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study

The role of polyphenols in cardiovascular disease

The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis.

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease

Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe.